Market Research Logo

Global Capecitabine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Global Capecitabine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

Scope of the Report:
This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Capecitabine is a prescription medication used to treat breast cancer and cancer of the colon or rectum. Capecitabine belongs to a group of drugs called antimetabolites which work by interfering with DNA production, stopping cells from multiplying. The medication comes in tablet form and is usually taken twice daily, within 30 minutes after the end of a meal. The proportion of breast cancer with Handle in 2016 is about 40%, and the proportion of colorectal cancer in 2016 is about 31.94%.
Cancer clinical treatment projects have led to the increasing demand for Capecitabine. Increasing Cancer incidence across the globe, especially in the Asia-Pacific is another major factor, driving the growth of the Capecitabine market during the forecast period.
The worldwide market for Capecitabine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Roche
Teva
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
500 mg
150 mg

Market Segment by Applications, can be divided into
Breast Cancer
Colorectal Cancer
Stomach Cancer

There are 15 Chapters to deeply display the global Capecitabine market.
Chapter 1, to describe Capecitabine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Capecitabine, with sales, revenue, and price of Capecitabine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Capecitabine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Capecitabine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Capecitabine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


1 Market Overview
1.1 Capecitabine Introduction
1.2 Market Analysis by Type
1.2.1 500 mg
1.2.2 150 mg
1.3 Market Analysis by Applications
1.3.1 Breast Cancer
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Capecitabine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Teva
2.2.1 Business Overview
2.2.2 Capecitabine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Teva Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Mylan
2.3.1 Business Overview
2.3.2 Capecitabine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mylan Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Hikma
2.4.1 Business Overview
2.4.2 Capecitabine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Hikma Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Hengrui Medicine
2.5.1 Business Overview
2.5.2 Capecitabine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hengrui Medicine Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Cipla
2.6.1 Business Overview
2.6.2 Capecitabine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cipla Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Reliance Group
2.7.1 Business Overview
2.7.2 Capecitabine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Reliance Group Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Hetero
2.8.1 Business Overview
2.8.2 Capecitabine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Hetero Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Capecitabine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Capecitabine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Capecitabine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Capecitabine Manufacturer Market Share in 2017
3.3.2 Top 6 Capecitabine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Capecitabine Market Analysis by Regions
4.1 Global Capecitabine Sales, Revenue and Market Share by Regions
4.1.1 Global Capecitabine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Capecitabine Revenue and Market Share by Regions (2013-2018)
4.2 North America Capecitabine Sales and Growth Rate (2013-2018)
4.3 Europe Capecitabine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Capecitabine Sales and Growth Rate (2013-2018)
4.5 South America Capecitabine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Capecitabine Sales and Growth Rate (2013-2018)
5 North America Capecitabine by Countries
5.1 North America Capecitabine Sales, Revenue and Market Share by Countries
5.1.1 North America Capecitabine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Capecitabine Revenue and Market Share by Countries (2013-2018)
5.2 United States Capecitabine Sales and Growth Rate (2013-2018)
5.3 Canada Capecitabine Sales and Growth Rate (2013-2018)
5.4 Mexico Capecitabine Sales and Growth Rate (2013-2018)
6 Europe Capecitabine by Countries
6.1 Europe Capecitabine Sales, Revenue and Market Share by Countries
6.1.1 Europe Capecitabine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Capecitabine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Capecitabine Sales and Growth Rate (2013-2018)
6.3 UK Capecitabine Sales and Growth Rate (2013-2018)
6.4 France Capecitabine Sales and Growth Rate (2013-2018)
6.5 Russia Capecitabine Sales and Growth Rate (2013-2018)
6.6 Italy Capecitabine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Capecitabine by Countries
7.1 Asia-Pacific Capecitabine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Capecitabine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Capecitabine Revenue and Market Share by Countries (2013-2018)
7.2 China Capecitabine Sales and Growth Rate (2013-2018)
7.3 Japan Capecitabine Sales and Growth Rate (2013-2018)
7.4 Korea Capecitabine Sales and Growth Rate (2013-2018)
7.5 India Capecitabine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Capecitabine Sales and Growth Rate (2013-2018)
8 South America Capecitabine by Countries
8.1 South America Capecitabine Sales, Revenue and Market Share by Countries
8.1.1 South America Capecitabine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Capecitabine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Capecitabine Sales and Growth Rate (2013-2018)
8.3 Argentina Capecitabine Sales and Growth Rate (2013-2018)
8.4 Colombia Capecitabine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Capecitabine by Countries
9.1 Middle East and Africa Capecitabine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Capecitabine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Capecitabine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Capecitabine Sales and Growth Rate (2013-2018)
9.3 UAE Capecitabine Sales and Growth Rate (2013-2018)
9.4 Egypt Capecitabine Sales and Growth Rate (2013-2018)
9.5 Nigeria Capecitabine Sales and Growth Rate (2013-2018)
9.6 South Africa Capecitabine Sales and Growth Rate (2013-2018)
10 Global Capecitabine Market Segment by Type
10.1 Global Capecitabine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Capecitabine Sales and Market Share by Type (2013-2018)
10.1.2 Global Capecitabine Revenue and Market Share by Type (2013-2018)
10.2 500 mg Sales Growth and Price
10.2.1 Global 500 mg Sales Growth (2013-2018)
10.2.2 Global 500 mg Price (2013-2018)
10.3 150 mg Sales Growth and Price
10.3.1 Global 150 mg Sales Growth (2013-2018)
10.3.2 Global 150 mg Price (2013-2018)
11 Global Capecitabine Market Segment by Application
11.1 Global Capecitabine Sales Market Share by Application (2013-2018)
11.2 Breast Cancer Sales Growth (2013-2018)
11.3 Colorectal Cancer Sales Growth (2013-2018)
11.4 Stomach Cancer Sales Growth (2013-2018)
12 Capecitabine Market Forecast (2018-2023)
12.1 Global Capecitabine Sales, Revenue and Growth Rate (2018-2023)
12.2 Capecitabine Market Forecast by Regions (2018-2023)
12.2.1 North America Capecitabine Market Forecast (2018-2023)
12.2.2 Europe Capecitabine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Capecitabine Market Forecast (2018-2023)
12.2.4 South America Capecitabine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Capecitabine Market Forecast (2018-2023)
12.3 Capecitabine Market Forecast by Type (2018-2023)
12.3.1 Global Capecitabine Sales Forecast by Type (2018-2023)
12.3.2 Global Capecitabine Market Share Forecast by Type (2018-2023)
12.4 Capecitabine Market Forecast by Application (2018-2023)
12.4.1 Global Capecitabine Sales Forecast by Application (2018-2023)
12.4.2 Global Capecitabine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report